Morbidity Management and Disability Prevention for Blinding Trachoma and Lymphatic Filariasis

Funding Opportunity Number: SOL-OAA-13-000107 Opportunity Category: DiscretionaryFunding Instrument Type: Cooperative AgreementCategory of Funding Activity: HealthCFDA Number: Eligible Applicants Others (see text field entitled "Additional Information on Eligibility" for clarification)Agency Name: USAIDClosing Date: Aug 05, 2013Award Ceiling: $35,000,000Expected Number of Awards: 1Creation Date: Jul 08, 2013Funding Opportunity Description: More than 1 billion people worldwide suffer from a group of painful and debilitating diseases collectively referred to as neglected tropical diseases (NTDs). These diseases disproportionately impact poor, rural, and marginalized populations, and contribute to compromised mental and physical development, childhood malnutrition, reduced school enrollment and performance, and diminished economic productivity. The United States Agency for International Development (USAID) focuses on control and elimination of seven NTDs that can be targeted with preventive chemotherapy, including: lymphatic filariasis (LF), blinding trachoma, onchocerciasis, schistosomiasis and three soil-transmitted helminthiases (STH). In addition to causing sickness, several of these diseases can also lead to severe and lifelong morbidity and disability. To address morbidity and disability caused by blinding trachoma and LF, USAID through its NTD Program seeks to award a five-year, $35 million Cooperative Agreement to support countr...
Source: Grants.gov - Category: Research Tags: Health Source Type: funding